AGT and diabetes mellitus: This study is the first to demonstrate that losartan, an Ang II type 1 receptor blocker, effectively prevents both muscular hypertrophy and redox imbalance in the gastrointestinal tract of STZ-induced diabetic rats, providing compelling evidence for the central role of local RAAS activation—particularly Ang II signaling—in the structural and oxidative changes associated with diabetes.